iosBio

Company profile

iosBio company profile

iosBio offers vaccine manufacturing, distribution, and delivery services. That develop OraProTM technology, these thermally stable viral vector-based vaccines can be delivered to the GI tract in capsule form. Vaccines can be developed quickly and cheaply using viral vectors, and administration via the gut elicits both mucosal and systemic immunity, allowing for repeated administration of the same vector. In contrast, injected viral vector injections only target systemic immunity and can only be used once or twice before developing immunity to the vector.